Pharmaceutical Separation Science Session Day two of HPLC 2025 concluded with a session on pharmaceutical separations chaired ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

The number of approved biologic drugs has risen steeply in the past decade 1. Of the 50 novel drugs approved by the US Food and Drug Administration (FDA) in 2021, 14 were biologics 2. Biologics are ...

Better Business Advice is recognizing TruDiagnostic in its 2026 assessment of Horvath Clock testing solutions. This mirrors a surge in interest in biological age evaluation as epigenetic tools ...

BIOPITCH, featured at the annual Florida Innovation Conference, highlights the state's most promising life sciences ventures ORLANDO, Fla., Dec. 15, 2025 /PRNewswire/ -- BioFlorida's annual BIOPITCH ...

Wasatch BioLabs (WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct ...

The life sciences industry is undergoing profound change. Rising R&D costs, extended development timelines, and increasingly complex regulatory environments have created immense pressure on biopharma ...

Uncertainty reigned early this year with the inauguration of President Donald Trump and his threats to impose tariffs and slash prescription drug prices. But as players in the biopharma industry have ...

The startup’s filing comes during a broader biotech recovery that’s made some industry watchers optimistic IPOs could rebound ...

At the BIO-Europe congress in Vienna, the session titled “From Roasts to Billions: Biopharma Investment Landscape” brought together leading voices from investment banking and venture capital to ...

Daura Gold Corp. (TSXV: DGC) ("Daura" or the "Company") is pleased to announce the commencement of Induced Polarization ...